Polymorphism of adiponectin (45T/G) and adiponectin receptor-2 (795G/A) in an Iranian population: relation with insulin resistance and response to treatment with pioglitazone in patients with type 2 diabetes mellitus

[1]  P. Rahimi-Moghaddam,et al.  Distribution and genotype frequency of adiponectin (+45 T/G) and adiponectin receptor2 (+795 G/A) single nucleotide polymorphisms in Iranian population. , 2011, Gene.

[2]  N. Al-Daghri,et al.  Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes , 2011, Molecular Biology Reports.

[3]  Shumin Deng,et al.  Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a Chinese Han population , 2011, Molecular Biology Reports.

[4]  D. Giugliano,et al.  Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Trial , 2010 .

[5]  P. Kern,et al.  Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids. , 2009, American journal of physiology. Endocrinology and metabolism.

[6]  J. Pankow,et al.  Influence of Waist on Adiponectin and Insulin Sensitivity in Adolescence , 2009, Obesity.

[7]  G. Latkovskis,et al.  Analysis of Polymorphisms at the Adiponectin Gene Locus in Association with Type 2 Diabetes, Body Mass Index and Cardiovascular Traits in Latvian Population , 2009 .

[8]  J. Skupień,et al.  Variants of the adiponectin gene and type 2 diabetes in a Polish population , 2009, Acta Diabetologica.

[9]  J. M. Fernández,et al.  Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. , 2008, The Journal of nutrition.

[10]  Jing Wu,et al.  The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients. , 2008, British journal of clinical pharmacology.

[11]  V. Nosikov,et al.  Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. , 2008, The review of diabetic studies : RDS.

[12]  Xiaochun Kang,et al.  ASSOCIATIONS BETWEEN 45T/G POLYMORPHISM OF THE ADIPONECTIN GENE AND PLASMA ADIPONECTIN LEVELS WITH TYPE 2 DIABETES , 2007, Clinical and experimental pharmacology & physiology.

[13]  D. Meyre,et al.  Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies , 2006, Expert Reviews in Molecular Medicine.

[14]  Morgan Bradley,et al.  POLYMORPHISMS IN THE ADIPONECTIN GENE AND RESPONSE TO PIOGLITAZONE Student Researcher : , 2006 .

[15]  E. Kang,et al.  Effects of Pro12Ala polymorphism of peroxisome proliferator‐activated receptor γ2 gene on rosiglitazone response in type 2 diabetes , 2005, Clinical pharmacology and therapeutics.

[16]  E. Kang,et al.  The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. , 2005, Diabetes care.

[17]  I. Papassotiriou,et al.  Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. , 2005, Clinical chemistry.

[18]  이현철,et al.  Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetes , 2005 .

[19]  M. Manns,et al.  Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. , 2004, American journal of physiology. Endocrinology and metabolism.

[20]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[21]  S. Kihara,et al.  Obesity, adiponectin and vascular inflammatory disease , 2003, Current opinion in lipidology.

[22]  P. Elder,et al.  Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance , 2003, Diabetes, obesity & metabolism.

[23]  Yu Wang,et al.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.

[24]  M. Matsuda,et al.  Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.

[25]  K. Clément,et al.  Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. , 2002, Human molecular genetics.

[26]  R. A. Norman,et al.  The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. , 2002, Diabetes.

[27]  T. Saruta,et al.  Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. , 2002, Clinical science.

[28]  C. Bogardus,et al.  Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. , 2002, Diabetes.

[29]  S. O’Rahilly,et al.  Induction of Adipocyte Complement-related Protein of 30 Kilodaltons by Ppar␥ Agonists: a Potential Mechanism of Insulin Sensitization , 2022 .

[30]  Lee-Ming Chuang,et al.  Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. , 2002, Diabetes care.

[31]  C. Dina,et al.  Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. , 2002, Diabetes.

[32]  M. Matsuda,et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.

[33]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[34]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[35]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[36]  M. Daly,et al.  Guilt by association , 2000, Nature Genetics.

[37]  S. Kihara,et al.  Genomic structure and mutations in adipose-specific gene, adiponectin , 2000, International Journal of Obesity.

[38]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[39]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[40]  E S Lander,et al.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.

[41]  E. Ravussin,et al.  Decreased Expression Of apM1 in Omental and Subcutaneous Adipose Tissue of Humans With Type 2 Diabetes , 2000, International journal of experimental diabetes research.

[42]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[43]  B. Spiegelman.  PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. , 1998, Diabetes.

[44]  D. Lockwood,et al.  Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione Troglitazone , 1997, Diabetes Care.

[45]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[46]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[47]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[48]  R. Kahn.  Causes of insulin resistance , 1995, Nature.

[49]  C. R. Kahn.  Diabetes. Causes of insulin resistance. , 1995, Nature.

[50]  Diabetes mellitus. Report of a WHO Study Group. , 1985, World Health Organization technical report series.